Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2024-12-05 2024-12-05
Drug Identification Number 02045737 02045737
Brand name ZESTORETIC ZESTORETIC
Common or Proper name Zestoretic 20/12.5 Zestoretic 20/12.5
Company Name SEARCHLIGHT PHARMA INC SEARCHLIGHT PHARMA INC
Ingredients HYDROCHLOROTHIAZIDE LISINOPRIL HYDROCHLOROTHIAZIDE LISINOPRIL
Strength(s) 12.5MG 20MG 12.5MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-11-01 2024-11-01
Actual start date 2024-11-01 2024-11-01
Estimated end date 2025-03-31 2025-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments